{"id":"NCT00757237","sponsor":"Gilead Sciences","briefTitle":"Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa","officialTitle":"An Open-Label, Randomized, Phase 3 Trial to Evaluate the Efficacy and Safety of Aztreonam for Inhalation Solution (AZLI) Versus Tobramycin Inhalation Solution (TIS) in an Intermittent Aerosolized Antibiotic Regimen in Subjects With Cystic Fibrosis Followed by an Open-Label, Single Arm Extension (European Union [EU] Only)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2010-05","completion":"2010-11","firstPosted":"2008-09-23","resultsPosted":"2011-07-04","lastUpdate":"2011-07-04"},"enrollment":274,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"Aztreonam for Inhalation Solution (AZLI)","otherNames":["aztreonam","AZLI","inhaled antibiotic"]},{"type":"DRUG","name":"Tobramycin Inhalation Solution (TIS)","otherNames":["tobramycin","TNS","inhaled antibiotic"]}],"arms":[{"label":"AZLI 75 mg 3 times a day (TID)","type":"EXPERIMENTAL"},{"label":"TIS 300 mg 2 times a day (BID)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to assess the comparative safety and effectiveness of aztreonam for inhalation solution versus tobramycin inhalation solution in adult and pediatric patients with cystic fibrosis (CF) and pulmonary Pseudomonas aeruginosa (PA) infection.","primaryOutcome":{"measure":"Relative Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted at Day 28","timeFrame":"Baseline and end of treatment Course 1 (Day 28)","effectByArm":[{"arm":"AZLI (75 mg TID)","deltaMin":8.35,"sd":1.7},{"arm":"TIS (300 mg BID)","deltaMin":0.55,"sd":1.77}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":16},"locations":{"siteCount":92,"countries":["United States","Austria","Belgium","Denmark","France","Germany","Ireland","Italy","Netherlands","Portugal","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["22985692"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":136},"commonTop":["Cough","Productive Cough","Oropharyngeal Pain","Pyrexia","Rales"]}}